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Theeffects of isoquinoline alkaloid berberine (BER) on spleen tissueCD4þCD25þFoxp3þ reg-
ulatory T (Treg) cells were evaluated in BALB/c mice. Here, BER was administered daily by
intraperitoneal injection at doses of 5 mg/kg and 10 mg/kg for 14 days. Following the expo-
sure, mice spleen cellularities, IL-10 production by splenocytes, and spleen Treg/CD4
þ cell
profileswere studied in all the test groups of animals. The results showed that a high dose of
BER (10 mg/kg) could decrease both the absolute and relative percentages of spleen Treg
cells as well as decrease the production of IL-10 by splenocytes in the treated mice
(p< 0.05). BER at 5 mg/kg did not appear to affect any of these parameters. Based on
thefindinghere, itwould seemthat BERhas effective immunostimulatory properties,which
contradicts the results fromother studies indicating immunosuppressive effects of BER. De-
pending on the doses of BER used, it might have a broad spectrum from immunosuppressivetributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any
properly cited.
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uate the effects of this natural product. Mechanistic studies are required, particularly in
case of redox state of the immune cells, to elucidate and determine how BER functions
to impart the toxicity effects demonstrated here and in other studies.1. Introduction
CD4þCD25þFoxp3þ regulatory T (Treg) cells are vital for
preserving self-tolerance [1,2] and play critical roles to
control immune system homeostasis [2]. Growing documents
indicate that Treg cells are able to inhibit the function of Th1,
Th2, Th17, and other effector cells, inhibit inflammation,
and prevent autoimmunity [3,4]. Therefore, the lack or
dysfunction of Treg cells often leads to autoimmune diseases,
such as systemic lupus erythematosus [5], type I diabetes,
and inflammatory bowel disease [2,6]. As a result, it seems
that conditions in which Treg cells are being promoted may
consequently alleviate the severity of autoimmune diseases.
Since ancient times, people have looked for cures for
illness in nature. The use of natural medicines has intensified
in recent times because of the low level of side effects, cost,
and efficacy against several human illnesses [7]. Berberine
(2,3-methylenedioxy-9,10-dimethoxyproto-berberine chlo-
ride; BER) is an isoquinoline alkaloidwith a broad spectrumof
pharmacologic and biochemical effects and is the main
active component in plants, such as Berberis spp. and gold-
enseal [8]. In traditional medicine, BER has been repeatedly
applied as an anticancer, antihypertension, antidiarrhea,
antiarrhythmia, and antibiotic agent. Moreover, there are
several studies suggesting the possibility of its application for
the treatment of autoimmunediseases. For instance, BERhas
been reported to play a role in the management of immune
inflammatory diseases, such as experimental autoimmune
encephalomyelitis (an animal model of multiple sclerosis)
[9e11], type 1 diabetes [12], rheumatoid arthritis [13,14],
experimental autoimmune tubulointerstitial nephritis [15],
and colitis [16]. In these studies, BER has been reported to
affect by activating dendritic cell apoptosis, inhibiting Th1
and Th17 differentiation, decreasing the permeability of
bloodebrain/intestinal epithelial barriers, and down-
regulating inflammatory cytokines and antibodies. However,
little is known about the role of natural compounds in con-
trolling the differentiation and functions of Treg cells.
Because Treg cells regulate the functions of effector T cells,
we hypothesized that some therapeutic herbs may suppress
inflammation by promoting Treg cell differentiation, thus
inhibiting inflammation and preventing autoimmunity.
Therefore, in this study, we aimed to evaluate the subacute
effects of BER on CD4þCD25þFoxp3þ Treg cells of the BALB/c
mice spleen.
2. Materials and methods
2.1. Animals
Male BALB/c mice (19e21 g; 6e8 weeks old) were pur-
chased from the Pasteur Institute (Tehran, Iran) and housedarimi G, et al., Decreased Levels
of Acupuncture and Meridian Studin standard laboratory conditions (25 2C and 40e70%
relative humidity) with a 12-hour day/night lighting cycle
throughout the experimental period. The mice were kept in
spacious polypropylene cages and provided ad libitum ac-
cess to standard rodent chow and filtered water. All mice
were acclimatized for 1 week prior to usage. The Ethnic
Council of Mashhad University of Medical Sciences (Mash-
had, Iran) approved all protocols used in this study.
2.2. Doses and treatment schedules
Twenty four mice were randomly divided into four groups (six
mice per group). Mice in the BER experimental groups were
injected intraperitoneally (IP) daily with a BER solution (98%;
Sigma, St. Louis, MO) prepared in dimethyl sulfoxide (DMSO)/
phosphate-buffered saline (PBS, pH7.4) solution (1:20, v/v) in
order to receive 5 mg or 10 mg BER/kg/d. Mice in the positive
control group received cyclophosphamide (Sigma) at 20 mg/
kg/d. Mice in the vehicle control group received only DMSO/
PBS injections. No injection volume ever exceeded 100 mL.
Mice were treated daily for 14 days. The doses of BER used
herewerebasedonthe studyofTsangetal, demonstrating the
anticarcinogenic effects of doses of 5 mg or 10 mg BER/kg in
mice [17]. The dose of cyclophosphamide was selected based
on the studies of Farsam et al and Rahnama et al [18,19].
2.3. Preparation of single-cell suspension
The spleen was placed in a small petri dish including 10 mL
RPMI-1640 media supplemented with 10% fetal bovine
serum, 100 U/mL penicillin, 100 mg/mL streptomycin, and
2mM glutamine. The spleen was teased, and the tissue
dispersion was centrifuged at 1200 rpm at 4C for 10 mi-
nutes. The supernatant was discarded, and the pellet was
resuspended in 3 mL of RBC lysing buffer containing 0.83%
NH4Cl in 100mM Tris buffer, pH 7.4 and kept at room tem-
perature for 3 minutes. The cells were washed thrice with
the media and suspended into 1 mL of the media containing
10% fetal bovine serum. Viability of cells was performed
using the trypan blue exclusion method [20].
2.4. Measurement of IL-10 production
In brief, aliquots of the isolated splenocytes (2 106 cells/
well) were placed into each well of 96-well plates, and
phytohemagglutinin-A (PHA; 5 mg/mL; final concentration)
was subsequently added to stimulate the cells. The cells
were incubated for 72 h at 37C before well supernatants
were collected and frozen at e70C until testing. Com-
mercial ELISA assay kit (R&D Systems, Minneapolis, MN) was
used to measure the levels of interleukin IL-10, according
to manufacturer’s instructions.of Spleen Tissue CD4þCD25þFoxp3þ Regulatory T Lymphocytes in
ies (2016), http://dx.doi.org/10.1016/j.jams.2016.10.003
Figure 1 Effects of subacute exposure to berberine on
ex vivo IL-10 production by mouse spleen cells. BERZ ber-
berine. Value is significantly different versus vehicle control at
**p< 0.01 or ***p< 0.001.
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Dcell subtyping
Levels (relative percentages) of splenic Treg cells were
determined using a FACSCalibur flow cytometer (BD, San
Jose, CA) and a mouse Treg cell staining kit (with isotype
control; FITC-anti-CD4, PE-Cy5- anti-CD25, and PE-Cy5-
anti-Foxp3; eBioscience, San Diego), according to the
manufacturer’s protocol. For each sample, a minimum of
10,000 events were captured. The absolute number of each
cell type in each spleen was determined by multiplying the
differential ratio of the subtypes by the total spleen cell
contents [21].
2.6. Statistical analysis
Data were statistically analyzed using Student t test to
determine significant differences in the data of the groups.
A p value< 0.05 was considered significant. Values were
expressed as mean S.E.
3. Results
Of all the treatments, only spleen cellularity decreased
significantly (p< 0.05) in cyclophosphamide-treated mice
compared with that in vehicle-treated mice. The absolute
(total) number of spleen tissue CD4þCD25þFoxP3þ Treg cells
associated with 10 mg/kg BER group was significantly
decreased compared with the corresponding values in tis-
sues recovered from vehicle control mice (Table 1). Using
the total numbers of CD4þ cells in each treatment group’s
cell population analyzed as a 100% baseline, the relative
percentages of spleen CD4þCD25þFoxP3þ Treg cells in
samples from the mice treated with 10 mg BER/kg and with
20 mg cyclophosphamide/kg were also significantly lower
than those in tumors from the vehicle control mice. How-
ever, BER at the dose of 5 mg/kg did not cause any signif-
icant change in these percentages. On the other hand, the
absolute number of spleen CD4þ T cells and their relative
percentages based on whole splenocyte levels in the sam-
ple set as a 100% value (from both 5 mg and10 mg BER/kg-
treated mice) did not show any significant changes
compared with the values from vehicle control group.
The effects of the treatment regimens on PHA-
stimulated splenocyte IL-10 production are shown in
Fig. 1. Significant decreases (in comparison with values
from cells from vehicle control mice) in IL-10 productionTable 1 Effects of subacute exposure to berberine on mouse s
Parameter Vehicle control BER
Spleen cellularity (107) 8.52 1.36 8.1
CD4þ cell (%) 27.55 1.97 31.8
CD4þ content (107) 2.35 0.42 2.5
CD4þCD25þFoxp3þ cell
(Treg; % of CD4
þ cells)
14.23 1.31 16.2
CD4þCD25þFoxp3þ cell
(Treg; content [107])
0.33 0.02 0.4
Value is significantly different versus vehicle control at *p< 0.05.
BER Z berberine.
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treated with 10 mg/kg dose of BER or with
cyclophosphamide.4. Discussion
Since recent studies have suggested the possibility of BER
usage as a therapeutic agent for some autoimmune dis-
eases, it is possibly thought that BER may be able to in-
crease the level of Treg cells. Surprisingly, our results
showed a decreased level of mice spleen Treg cells among
the 10 mg/kg BER-treated mice group. In addition, mice
treatment with BER at a dose of 10 mg/kg/d significantly
(p< 0.05) decreased the ex vivo IL-10 production of their
splenocytes in response to PHA (p< 0.01) relative to that by
control mice cells. Initially, it seems that our results
contradict the other researches regarding anti-
inflammatory/autoimmunity effects of BER because evi-
dence suggests that Treg cells are capable of inhibiting the
function of Th1, Th2, Th17, and other effector cells,
inhibiting inflammation, and preventing autoimmunity
[3,4]. There is a research in which BER ameliorates exper-
imental autoimmune neuritis by suppressing both cellularpleen CD4þ and CD4þCD25þFoxp3þ cells.
5 mg/kg BER 10 mg/kg Cyclophosphamide
6 1.33 6.12 0.59 5.77 1.52*
2 2.42 26.70 1.71 29.25 5.19
9 0.43 1.64 0.12 1.68 0.39
2 2.72 10.00 1.25* 9.08 1.04*
2 0.03 0.16 0.02* 0.15 0.04*
of Spleen Tissue CD4þCD25þFoxp3þ Regulatory T Lymphocytes in
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of the subacute effects of BER on mice immune system, the
results showed that a high dose of BER (10 mg/kg) could
suppress both cellular and humoral immune functions in the
treated mice. According to that study, it would seem that
BER has effective immunosuppressive properties due to its
antioxidative effects leading to changes in T and B cell
redox states required to act correctly [23].
The equilibrium between oxidizing and reducing agents
within T cells controls their redox state. Transient
controlled changes in the redox state, such as elevated
production of reactive oxygen species (ROS), are critical for
signaling and induction of various biological processes. Low
levels of ROS are reportedly vital for T cell function [24]. A
study has reported that small amounts of ROS are pivotal
for inducing transcription of nuclear factor kB and gene
expression of cytokines and receptors required for T cell
proliferation, highlighting an important role for cellular
redox environment on T cell function [25]. On the other
hand, inducible Treg cells originate as CD4 single-positive
cells from the thymus, following adequate antigenic stim-
ulation in the presence of cognate antigen and specialized
immunoregulatory cytokines, such as IL-10, differentiate
into CD25þ and FoxP3þ expressing Treg cells [26,27].
Therefore, a significant decrease in the spleen relative
percentage/absolute number of Treg cells as well as in IL-10
level in supernatant of splenocytes cultivation may be due
to the antioxidative effects of BER in neutralizing ROS and
consequently dysfunction of CD4þ cells that must be con-
verted to Treg cells. Moreover, Niedbala et al reported that
NO helped to induce the expansion of Treg cell populations
in situ. Thus, based on both the sets of findings, it is
plausible to believe that the observed decreases in Treg cell
levels in 10mg/kg BER mice here might be associated with
an inhibition of NO production possibly as a result of the
antioxidative effects of BER [28]. Of course, further studies
are needed to investigate those aforementioned
hypotheses.
Finally, the present study showed that BER at a high dose
(10 mg/kg/d for 14 days) imparted an inhibitory effect on
the mouse spleen Treg cells, whereas BER at a lower dose
(5 mg/kg/d for 14 days) did not seem to affect this
parameter. Further studies, including far more doses, are
required to better evaluate the effects of this natural
product. In addition, mechanistic studies are needed to
elucidate exactly how BER functions to impart Treg toxicity
demonstrated here. Further studies should be carried out
to determine the levels of ROS generated by mice spleen T
lymphocytes after BER administration and changes in the
activation of pathways in which ROS operate as a signaling
mediator for converting these cells to Treg cells. Addition-
ally, further researches should be performed concerning
BER to develop its potential use as an effective immuno-
modulator or coadjuvant in the treatment of diseases
originated from immune system dysfunction. As a recom-
mendation, in future studies, BER could be considered as a
good choice to be combined with acupuncture technique
since acupuncture has been demonstrated to enhance the
function and number of CD4þCD25þFoxp3þ Treg cells [29],
whereas in our study, it is shown that BER reduces the
number of Treg cells. Therefore, the combination of BER
with acupuncture (also known as herbal acupuncture) mayPlease cite this article in press as: Karimi G, et al., Decreased Levels
Mice Exposed to Berberine, Journal of Acupuncture and Meridian Studbe considered as a good strategy to modulate and shift
immune system to our desirable direction for the treatment
of some diseases. However, further studies are needed to
prove this hypothesis.
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